Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 671 of 6351
-
Can vitamin a derivative revive immune therapy for breast cancer?
Disease control Recruiting nowThis is a Phase II, open-label study evaluating the efficacy and safety of combined treatment (retinoic acid) with immune checkpoint inhibitor in HER2-negative breast cancer patients who progressed during previous immune checkpoint inhibitors.
Phase 2 • Sponsor: Fudan University • Aim: Disease control
Last updated Jun 27, 2026 07:57 UTC
-
Robots help recover brain power in Parkinson's, MS, and stroke patients
Symptom relief Recruiting nowThe goal of this clinical trial is to learn if sensor-based robotic upper limb rehabilitation can improve cognitive and motor functions in adults with neurological and neurodegenerative disorders, including Parkinson's disease, multiple sclerosis, and stroke. The main questions i…
Sponsor: IRCCS Centro Neurolesi Bonino Pulejo • Aim: Symptom relief
Last updated Jun 27, 2026 09:01 UTC
-
Gene therapy injection aims to heal diabetic foot sores
Disease control Recruiting nowThe main objective of the study is to evaluate the efficacy and safety of Neovasculgen® in a course dose of 2.4 mg in combination with standard drug therapy in patients with unilateral neuroischemic form of diabetic foot syndrome.
Phase 3 • Sponsor: JSC NextGen • Aim: Disease control
Last updated Jun 27, 2026 09:02 UTC
-
Firefighters get cutting-edge cancer screening in new pilot study
Diagnosis Recruiting nowThe purpose of this study is to further understand the clinical impact and follow-up steps that may be required based on using whole-body Magnetic Resonance Imaging (MRI) or whole-body ultrasound and blood tests to detect multiple cancers in firefighters. This study involves an …
Sponsor: Inova Health Care Services • Aim: Diagnosis
Last updated Jun 27, 2026 13:07 UTC
-
Could a quicker switch to stronger meds beat bipolar depression?
Disease control Recruiting nowBipolar disorders affect approximately 4.5 million people across the European Union (EU) and are associated with high annual healthcare and societal costs. Bipolar disorder I and II represent disorders that cause extreme fluctuation in a person's mood, energy, and ability to func…
Phase 3 • Sponsor: Dr. Inge Winter • Aim: Disease control
Last updated Jun 27, 2026 07:52 UTC
-
New radiation approach aims to shorten treatment for cervical cancer
Disease control Recruiting nowThe standard treatment for locally advanced cervical cancer is well established as a combination of chemotherapy and radiation, typically over 25-28 daily fractions with the addition of a brachytherapy boost to the primary tumor. An important component to treatment efficacy is ov…
Phase 1/2 • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated Jul 29, 2026 00:00 UTC
-
Can a bone graft improve ACL surgery outcomes?
Disease control Recruiting nowAll patients will be randomly assigned using a computer randomization algorithm to one of two matched cohort groups. Patients will not be advised which group they belong to until after the completion of the study. One group will be treated with autologous bone graft for bone pate…
Sponsor: University of Arizona • Aim: Disease control
Last updated Aug 16, 2026 00:00 UTC
-
Engineered immune cells take on lupus and scleroderma in new trial
Disease control Recruiting nowCAR T-cell Therapy Targeting CD19 and BCMA in Patients With Relapse/Refractory Autoimmune Diseases
Phase 1 • Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Disease control
Last updated Jun 27, 2026 07:52 UTC
-
Can a new Long-Acting injection replace opioids after knee surgery?
Symptom relief Recruiting nowParticipants are being invited to take part in a research study about pain control after total knee replacement surgery (also called total knee arthroplasty or TKA). The goal of this study is to see if a new long-acting medication, called Zynrelef, can control pain after surgery …
Phase 4 • Sponsor: Henry Ford Health System • Aim: Symptom relief
Last updated Aug 22, 2026 00:00 UTC
-
Can a 5-Week online course turn bystanders into protectors? a trial puts the MOON program to the test
Prevention OngoingThis research project will develop, deliver, and assess the efficacy of a new sexual violence (SV) prevention program for college students. The MOON program (Moving ON against sexual violence) aims to prevent sexual violence amongst university students, who are known to be an at-…
Sponsor: Universidade do Porto • Aim: Prevention
Last updated Jul 24, 2026 00:00 UTC
-
One shot for two threats? BioNTech tests combo Flu-COVID vaccine
Vaccine CompletedThe purpose of this study is to learn about how the flu and COVID vaccines act when given alone or when mixed together. This study is seeking healthy participants aged 18 or older. All participants in this study will receive only 1 shot to their arm, either a flu or COVID vaccin…
Phase 1/2 • Sponsor: BioNTech SE • Aim: Vaccine
Last updated Jun 27, 2026 08:14 UTC
-
New daily pill could stop menstrual migraines before they start
Prevention OngoingA migraine attack is a moderate or severe headache that usually occurs on one side of the head and is often throbbing or pulsating. The headache is often accompanied by sensitivity to light, sensitivity to sound, nausea, or other symptoms. Menstrual migraine (MM) attacks are migr…
Phase 3 • Sponsor: AbbVie • Aim: Prevention
Last updated Sep 06, 2026 00:00 UTC
-
New drug could protect unborn babies from dangerous bleeding disorder
Disease control Recruiting nowThe purpose of this study is to assess the efficacy and safety of nipocalimab in reducing the risk of severe fetal and neonatal alloimmune thrombocytopenia (FNAIT).
Phase 3 • Sponsor: Janssen Research & Development, LLC • Aim: Disease control
Last updated Aug 30, 2026 00:00 UTC
-
New drug aims to stop CIDP relapses in its tracks
Disease control Recruiting nowThe purpose of this Phase 3 study is to demonstrate the efficacy of claseprubart (DNTH103) as compared to placebo in participants with chronic inflammatory demyelinating polyneuropathy (CIDP).
Phase 3 • Sponsor: Dianthus Therapeutics • Aim: Disease control
Last updated Sep 04, 2026 00:00 UTC
-
New tool aims to stop depression before it starts
Prevention Recruiting nowDepression is a highly prevalent and disabling mental health problem. One way of preventing depression is to stop it before it happens through effective self-management. Working with potential users, a coach-guided, personalized depression risk communication tool (PDRC) was devel…
Sponsor: Dalhousie University • Aim: Prevention
Last updated Jun 26, 2026 12:36 UTC
-
New combo drug CagriSema shows promise for major weight loss in 3-Year trial
Disease control OngoingThis study will look at how well CagriSema helps people with obesity lose weight compared to a "dummy medicine". CagriSema is a new medicine developed by Novo Nordisk. CagriSema cannot yet be prescribed by doctors. The study has two parts: First part is called the main phase and …
Phase 3 • Sponsor: Novo Nordisk A/S • Aim: Disease control
Last updated Jun 27, 2026 08:12 UTC
-
New hope for NF1 patients: experimental drug targets painful nerve tumors
Disease control Recruiting nowThe trial will be an open label, single arm, phase 2 study to assess the tolerability and efficacy of HLX-1502 in participants with NF1 that are 16 years or older in age with progressive and/or symptomatic PN. This study will also investigate the safety and efficacy of HLX-1502 i…
Phase 2 • Sponsor: Healx Limited • Aim: Disease control
Last updated Jul 31, 2026 00:00 UTC
-
Supercharged immune cells take on tough pancreatic cancer
Disease control Recruiting nowThis study is to investigate the safety and efficacy of gene-edited tumor infiltrating lymphocyte (GC203 TIL) therapy in patients with pancreatic ductal adenocarcinoma. Gene-edited TILs are expanded from tumor resections or biopsies and infused i.v. into the patient after NMA lym…
Early phase 1 • Sponsor: Shanghai Juncell Therapeutics • Aim: Disease control
Last updated Aug 07, 2026 00:00 UTC
-
New hope for relapsed leukemia: targeted drug combo enters human trials
Disease control Recruiting nowTo determine the efficacy of the combination of tagraxofusp, cladribine, and cytarabine.
Phase 1/2 • Sponsor: Stanford University • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC
-
Could a daily pill help tackle obesity? a new trial puts it to the test
Disease control CompletedThe study is testing a new study medicine called NNC0487-0111 for weight control in Chinese people with Body mass index (BMI) greater than or equal to (\>=) 24 kilogram per square meter (kg/m\^2). The aim of this study is to find out how safe the study medicine is and how it beha…
Phase 1 • Sponsor: Novo Nordisk A/S • Aim: Disease control
Last updated Aug 27, 2026 00:00 UTC